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introduction: While transradial PCI (TRI) reduces access-site complications and bleeding over transfemoral (TFI), less is known about its economic 
impact on hospitals.
methods: Hospital costs in 7,121 consecutive PCI procedures from January 1, 2010 to March 31, 2011 were analyzed using data from cost 
accounting systems at five US hospitals. Independent costs of TRI were identified using propensity scoring methods with inverse probability 
weighting. Endpoints of interest were cost, bleeding, in-hospital mortality, and length of stay and further stratified by pre-procedural bleeding risk.
results: TRI was associated with shorter length of stay (LOS) (2.5 vs. 3.0 days, P<0.001) and fewer bleeding events (1.1% vs. 2.4%, adjusted OR 
0.61, 95% CI 0.34-1.07, P=0.086). Adjusted total costs of TRI and TFI are shown in Table 1. In TRI patients, adjusted cost savings were $830 (95% CI 
$296-$1,364, p<0.001). The total cost attributed to bleeding events and increased LOS was $99 (12%) and $414 (50%), respectively. Total savings 
increased by greater risk of bleeding: low risk $642 (95% CI $43-$1,236, p=0.035), moderate risk $706 (95% CI $104-$1,308, p=0.029), and high 
risk $1,621 (95% CI $271-$2,971, p=0.039).
conclusions: There are large cost-savings exceeding $800 per patient associated with TRI driven by decreased LOS as opposed to fewer bleeding 
events. Increasing TRI adoption may result in large cost-savings to hospitals. 
N Radial PCI Femoral PCI Difference P value
All patients 7121
$18,764
(16,417-20,900)
$19,594
(17,283-21,784)
$830
(296-1,364)
<0.001
Low bleeding risk 2292
$17,947
(13,953-21,338)
$18,588
(14,570-21,809)
$642
(43-1,242)
0.035
Moderate bleeding risk 3541
$18,469
(14,998-22,330)
$19,175
(15,764-22,977)
$706
(104-1,308)
0.029
High bleeding risk 1288
$21,284
(13,488-27,205)
$22,905
(14,613-28,579)
$1,621
(271-2,971)
0.038
